| 000 | 01468 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250515032149.0 | ||
| 264 | 0 | _c20061010 | |
| 008 | 200610s 0 0 eng d | ||
| 022 | _a0042-6822 | ||
| 024 | 7 |
_a10.1016/j.virol.2006.05.021 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKoval, Christine E | |
| 245 | 0 | 0 |
_aRelative replication fitness of efavirenz-resistant mutants of HIV-1: correlation with frequency during clinical therapy and evidence of compensation for the reduced fitness of K103N + L100I by the nucleoside resistance mutation L74V. _h[electronic resource] |
| 260 |
_bVirology _cSep 2006 |
||
| 300 |
_a184-92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAlkynes |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xpharmacology |
| 650 | 0 | 4 | _aBenzoxazines |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aCyclopropanes |
| 650 | 0 | 4 |
_aDrug Resistance, Viral _xgenetics |
| 650 | 0 | 4 | _aGenes, Viral |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aOxazines _xpharmacology |
| 650 | 0 | 4 |
_aRNA-Directed DNA Polymerase _xgenetics |
| 650 | 0 | 4 | _aVirus Replication |
| 700 | 1 | _aDykes, Carrie | |
| 700 | 1 | _aWang, Jiong | |
| 700 | 1 | _aDemeter, Lisa M | |
| 773 | 0 |
_tVirology _gvol. 353 _gno. 1 _gp. 184-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.virol.2006.05.021 _zAvailable from publisher's website |
| 999 |
_c16390424 _d16390424 |
||